Clinical Trial Update: Symptom Based Performance of Airway Clearance After Starting Highly Effective Modulators for Cystic Fibrosis (SPACE-CF) [NA]

View source ↗

Summary

SPACE-CF, a trial examining symptom-based airway clearance after initiating highly effective CF modulators, has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Cystic Fibrosis, Mucociliary Clearance Defect | NA | Status: TERMINATED